Eugene Varfolomeev

发表

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

Vishva M Dixit, V. Dixit, J. Blankenship, 2007, Cell.

c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation*

W. Fairbrother, K. Deshayes, K. Zobel, 2008, Journal of Biological Chemistry.

(Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways.

D. Vučić, Domagoj Vucic, Eugene Varfolomeev, 2008, Cell cycle.

(Un)expected roles of c-IAPs in apoptotic and NFκB signaling pathways

D. Vučić, Domagoj Vucic, Eugene Varfolomeev, 2008 .

Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax

Peter Schow, D. Lawrence, A. Ashkenazi, 2002, Nature Medicine.

Immunoaffinity enrichment coupled to quantitative mass spectrometry reveals ubiquitin-mediated signaling events.

Donald S Kirkpatrick, D. Kirkpatrick, Lilian Phu, 2015, Journal of molecular biology.

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Vishva M. Dixit, V. Dixit, J. Blankenship, 2007, Cell.

Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).

Zhaoyang Wen, Brigitte Maurer, Vickie Tsui, 2012, Journal of medicinal chemistry.

Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.

Alexandre Masselot, Donald S Kirkpatrick, Corey E Bakalarski, 2015, The Biochemical journal.